Digest Network Come funziona
Network
/
Società
Ci
Non verificato

Circle Pharma, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaFinanzaOncologiaSalute

15 comunicati stampa

Guarda tutti i comunicati
01/12/2025
Biotecnologia
Farmaceutica
Salute
Oncologia
Mercato del lavoro
Circle Pharma Appoints Anne E. Borgman, M.D., as Chief Medical Officer
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
04/11/2025
Associazioni/Professionisti
Oncologia
Salute
Finanza
Farmaceutica
Biotecnologia
Eventi
Circle Pharma Announces Participation in Upcoming Investor Conferences
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
03/11/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Mercato del lavoro
Circle Pharma Appoints Rob Lauzen as Chief Financial Officer
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
23/10/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Industria
Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
14/10/2025
Scienza
Finanza
Medicina - Varie
Associazioni/Professionisti
Biotecnologia
Salute
Farmaceutica
Oncologia
Eventi
Circle Pharma Announces Upcoming Poster Presentation Highlighting the Anti-tumor Potential of Cyclin D1 RxL Inhibition at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
25/09/2025
Eventi
Industria
Scienza
Associazioni/Professionisti
Farmaceutica
Oncologia
Finanza
Vetrine/Shopping
Sanità
Infanzia
Medicina - Varie
Biotecnologia
Salute
Circle Pharma Announces Poster Presentation Highlighting the Potential of CID-078, a First-in-class Oral Cyclin A/B RxL Inhibitor, at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
02/09/2025
Associazioni/Professionisti
Oncologia
Salute
Finanza
Farmaceutica
Biotecnologia
Eventi
Web e Social Network
Circle Pharma to Participate in Upcoming Investor Conferences
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
20/08/2025
Scienza
Libri/Editoria
Comunicazione
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Oncologia
Industria
Circle Pharma Announces Publication in Nature Demonstrating Robust Pre-clinical Anti-tumor Activity of Cyclin A/B RxL Inhibition
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
16/06/2025
Oncologia
Associazioni/Professionisti
Salute
Igiene alimentare
Finanza
Farmaceutica
Biotecnologia
Industria
Circle Pharma Receives FDA Orphan Drug Designation for CID-078 for the Treatment of Small Cell Lung Cancer
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0
27/05/2025
Eventi
Scienza
Finanza
Biotecnologia
Medicina - Varie
Associazioni/Professionisti
Farmaceutica
Salute
Oncologia
Preclinical Data on Circle Pharma’s CID-078 Featured in Poster Presentation at Advances in Neuroblastoma Research Meeting
Fonte
Circle Pharma, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0